Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Company price
0.039 AUD 0.00(0%)
Last update at 2026-11-12T01:33:00Z
VOLUME
7
Market Cap
3.47M

Momentum Score

…

Visionflex Group Limited, together its subsidiaries, engages in the provision of healthcare, telehealth, and remote diagnostic solutions in Australia. It operates through Visionflex and Corporate head office segments. The company offers Virtual healthcare solutions and peripheral medical devices that integrate into proprietary developed software for remote diagnostics and patient care. It serves primary health networks, local health districts, residential aged care facilities, aboriginal community-controlled health organisations, and private healthcare organisations. The company was formerly known as 1st Group Limited and changed its name to Visionflex Group Limited in November 2023. Visionflex Group Limited was incorporated in 2009 and is based in Warriewood, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.04
Low
0.04
High
52 Week Price Range
0.03
Low
0.12
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Publicly available information on Visionflex Group Ltd (ASX: VFX) is limited and company disclosures and analyst coverage are sparse, so a definitive description of its core business is not possible from open sources. Prospective investors should review the company's filings for details; long-term attractiveness would depend on demonstrated revenue sustainability, scalable operations and a defensible market position.

Key investment risks include limited public disclosure and liquidity, execution and operational risk typical of small listed companies, and potential need for additional financing.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.04
Dividend Yield
-
Revenue TTM
4.18M
Revenue Per Share
0.05
Gross Profit TTM
-0.78M
Debt / Equity
-39.36
ROE
-
Net Debt
-1.04M
ROCE
-918.53%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -0.60M -3.73M -2.15M -3.90M -6.80M
Net income -0.06M -3.19M -1.83M -3.66M -6.82M
Selling general administrative - 6.75M 4.95M 6.23M 7.86M
Gross profit -0.89M -2.42M 3.94M 3.41M 4.83M
Reconciled depreciation - - 0.02M 0.03M 0.03M
Ebit -2.11M -3.44M - - -
Ebitda -2.06M -3.37M - - -
Depreciation and amortization 0.06M 0.07M - - -
Operating income -2.11M -3.90M -1.64M -3.58M -3.63M
Other operating expenses 6.25M 8.09M - - -
Interest expense 0.16M 0.29M 0.81M 0.31M 0.34M
Tax provision - -0.53M -0.62M -0.62M 0.02M
Interest income - 0.29M 0.00M 0.00M 0.00M
Net interest income - - -0.81M -0.31M -0.34M
Extraordinary items - 0.11M - - -
Income tax expense -0.54M -0.53M - - -
Total revenue 4.14M 4.19M 6.65M 4.47M 4.83M
Total operating expenses 1.22M 1.48M - - -
Cost of revenue 5.02M 6.61M 2.71M 1.06M -
Total other income expense net 1.52M 0.17M 0.30M -0.01M -2.82M
Net income from continuing ops - - -1.53M -3.28M -6.82M
Net income applicable to common shares - -3.09M - - -
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 3.09M 3.39M 2.88M 3.36M 4.18M
Intangible assets 0.01M 0.00M 0.01M 0.01M 0.01M
Other current assets 0.11M - 0.01M 0.02M 0.19M
Total liab 3.11M 5.22M 10.99M 10.10M 8.07M
Total stockholder equity -0.01M -1.82M -8.11M -6.74M -3.89M
Other current liab 0.85M - 1.41M 0.25M -
Common stock 51.22M 48.98M - - -
Capital stock - - 40.10M 40.27M 39.29M
Retained earnings -54.72M -50.80M -51.57M -49.73M -46.01M
Cash 1.62M - 1.16M 1.44M 2.01M
Cash and equivalents - 1.89M - - -
Total current liabilities 2.86M 3.68M 4.01M 4.04M 3.95M
Current deferred revenue 1.43M - - - -
Net debt -1.04M - 5.67M 4.61M 1.99M
Short term debt 0.43M 0.97M - - -
Short long term debt - - 0.00M 0.01M -
Short long term debt total 0.58M - - - -
Property plant equipment - 0.13M - - -
Total current assets 2.99M 3.26M 2.82M 3.33M 4.12M
Net receivables 1.02M 0.38M 0.30M 0.52M 0.39M
Long term debt - 1.50M 6.83M 6.05M 4.00M
Inventory 0.23M 0.26M 0.65M 0.60M 0.57M
Accounts payable 0.16M - 0.47M 1.05M 1.42M
Accumulated other comprehensive income 3.48M - - - -
Non current assets total 0.10M - 0.06M 0.03M 0.06M
Long term debt total - 1.50M - - -
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - - 0.28M 0.72M -0.02M
Total cashflows from investing activities -0.02M -0.03M - - -
Total cash from financing activities 1.02M 3.92M 0.80M 2.36M 4.59M
Net income -0.06M -3.21M -1.83M -3.66M -6.82M
Change in cash -0.27M 0.73M -0.28M -0.56M 1.77M
Begin period cash flow 1.89M 1.16M 1.44M 2.01M 0.24M
End period cash flow 1.62M 1.89M 1.16M 1.44M 2.01M
Total cash from operating activities -1.26M -3.16M - - -
Issuance of capital stock - - 0.02M 0.91M 3.84M
Depreciation 0.06M 0.07M - - -
Change to inventory 0.03M 0.39M - - -
Change to account receivables -0.05M -0.04M - - -
Other cashflows from financing activities -0.09M - - - -
Capital expenditures 0.01M 0.03M 0.02M 0.03M 0.02M
Change in working capital -0.22M -0.68M - - -
Other non cash items -1.04M 0.65M - - -
Free cash flow -1.27M -3.19M -1.38M -3.68M -2.82M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
VFX
Visionflex Group Ltd
-
-%
0.04 - - 0.83 31.44 0.59 -12.21
PME
Pro Medicus Ltd
-4.52
2.18%
202.79 81.98 106.38 83.13 43.70 74.38 95.34
4DX
4DMEDICAL Ltd
-0.06
2.53%
2.31 - - 205.57 8.53 170.03 -7.29
CGS
Cogstate Ltd
0.12
3.30%
3.76 33.80 27.86 9.59 6.95 6.35 19.27
AYA
ARTRYA Ltd
-0.14
3.91%
3.44 - - 20505.14 7.00 16927.51 0.33

Profile*

Visionflex Group Ltd

Visionflex Group Limited, together its subsidiaries, engages in the provision of healthcare, telehealth, and remote diagnostic solutions in Australia. It operates through Visionflex and Corporate head office segments. The company offers Virtual healthcare solutions and peripheral medical devices that integrate into proprietary developed software for remote diagnostics and patient care. It serves primary health networks, local health districts, residential aged care facilities, aboriginal community-controlled health organisations, and private healthcare organisations. The company was formerly known as 1st Group Limited and changed its name to Visionflex Group Limited in November 2023. Visionflex Group Limited was incorporated in 2009 and is based in Warriewood, Australia.

Prosperity Parade, Warriewood, NSW, Australia, 2102

61 2 8914 4000

Name Title Year Born
Mr. Joshua Mundey Chief Executive Officer NA
Mr. James Aulsebrook Chief Financial Officer NA
Michael Kafruni Chief Operating Officer NA
Mr. Ben Robinson Head of Growth NA
Mr. Michael John Harman Head of Visionflex NA
Ms. Elizabeth Spooner Company Secretary NA
Ms. Maria Clemente Company Secretary NA
Mr. Joshua Mundey Chief Executive Officer NA
Mr. James Aulsebrook Chief Financial Officer NA
Michael Kafruni Chief Operating Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…